Topic: REGENERON
16 results were found.
Regeneron to acquire 2seventy’s cell therapy pipeline - February 1, 2024
Regeneron Pharmaceuticals to acquire Decibel Therapeutics in $109 million deal - August 10, 2023
FDA bans Eli Lilly, Regeneron antibody use in COVID-19 patients infected by omicron - December 1, 2022
Regeneron Q3 revenues decreased 15% - November 4, 2022
Regeneron Q2 revenues decreased by 44% - August 4, 2022
Regeneron Q4 revenues increased by 104% - February 5, 2022
FDA okays Regeneron COVID-19 antibody as preventive in high-risk settings - July 31, 2021
New York: Regeneron intends to invest $1.8 billion, create 1,000 jobs - July 15, 2021
Roche and Regeneron to significantly increase supply of REGN-COV2 antibody for coronavirus - August 19, 2020
U.S. signs $450 million contract with Regeneron for coronavirus therapy - July 7, 2020
Tony Coles elected to Regeneron board of directors - February 1, 2017
Regeneron announces election of two directors - September 14, 2016
Regeneron Pharma to invest $150 million in Tarrytown, N.Y. - November 12, 2015
Robert A. Ingram elected to Regeneron board of directors - April 7, 2014
Christine A. Poon elected to Regeneron board of directors - November 15, 2010
Regeneron Pharmaceuticals: Michael Aberman new vice president - March 23, 2010